Introduction/Overview
In the treasure trove of natural products, indole alkaloids continue to provide valuable lead compounds for modern drug development due to their complex chemical structure and extensive biological activity. Vincamine, a monoterpenoid indole alkaloid isolated from Madagascar's Changchun flower, has attracted much attention since its discovery due to its unique cerebral vascular activity. In history, vincamine and its semi synthetic derivatives (such as vinpocetine) have been used as vasodilators and metabolic enhancers in clinical practice for decades, mainly to improve cognitive dysfunction and symptoms associated with cerebral vascular dysfunction. However, with the continuous deepening of modern molecular pharmacology and disease biology research, the biological landscape of vincamine has far exceeded the traditional scope of vasodilation. In recent years, studies have found that vinblastine can be used as an agonist of G protein coupled receptor 40 (GPR40), showing significant beta cell protection and potential to improve glucose homeostasis, which opens a new window for its application in the treatment of type 2 diabetes (T2DM). This article aims to systematically review the chemical properties, plant sources, multidimensional pharmacological activities, molecular mechanisms of action, pharmacological characteristics, and clinical application prospects of vincamine in cerebrovascular and metabolic diseases, in order to provide a comprehensive scientific perspective for the deep development and reuse of this classic natural product.
Chemical structure and physicochemical properties
The chemical name of vincamine is (3 α, 14 β, 16 α) -14,15-dihydro-14-hydroxyivory ene-3-carboxylic acid methyl ester, with a CAS number of 1617-90-9. Structurally, vincamine belongs to the "ivory tannin" type of monoterpene indole alkaloids. Its molecular skeleton consists of an indole nucleus (dihydroindole) fused with a nine membered nitrogen-containing heterocyclic ring (vincamine ring), forming a complex tricyclic system. The C-3 position is connected to a methyl ester group, while the C-14 position is connected to a hydroxyl group. These functional groups have a decisive impact on its biological activity and physicochemical properties.
The molecular formula of Changchun amine is C21H26N2O3, with a molecular weight of 354.45 g/mol. The calculated lipid water partition coefficient (LogP) is approximately 2.41, indicating that the compound has moderate lipophilicity, which is consistent with its ability to penetrate the blood-brain barrier. Its topological polar surface area (TPSA) is 54.7 Å ², which is relatively small and further supports its good membrane permeability. The water solubility measured in the experiment is about 0.4132 mg/mL, which belongs to the range of slightly soluble to insoluble. This to some extent limits the development of its formulations, which usually require the production of salts (such as vincamine tartrate) or the use of special drug delivery systems to improve bioavailability. The key pharmacological parameters show that vincamine has a high blood-brain barrier permeability, which is highly matched with its main central nervous system indications. In addition, its hERG inhibition risk is negative, and the Ames test result is 0.0, indicating that its cardiac toxicity risk and genetic toxicity risk are relatively low, and it has a relatively good safety basis.
Plant sources and extraction methods
Changchun amine mainly comes from the Apocynaceae plant Madagascar Changchun flower（Catharanthus roseus (L.) G. Don）， This plant is native to Madagascar and is now widely distributed in tropical and subtropical regions around the world. It is worth noting that Changchun flower is the source plant of the famous anti-cancer drugs Changchun alkaloids and Changchun alkaloids, and Changchun amine, as one of the alkaloids with relatively high content, is usually extracted from the aboveground parts (leaves and tender branches) of plants.
The traditional extraction method is mainly based on solvent extraction. The dried and crushed plant materials of Changchun flower are first extracted using polar organic solvents such as methanol, ethanol, or acidified ethanol. After concentrating the extract, the alkaline properties of alkaloids are utilized to extract through acidic water (such as dilute hydrochloric acid or dilute sulfuric acid). After alkalization (such as ammonia water), total alkaloids are precipitated. Subsequently, high-purity vincamine can be obtained by separation and purification using techniques such as silica gel column chromatography, high-performance liquid chromatography (HPLC), or countercurrent chromatography. With the development of technology, green extraction techniques such as ultrasound assisted extraction and microwave-assisted extraction have also been applied to improve extraction efficiency and reduce solvent consumption. Due to the significant influence of variety, origin, harvest season, and growth conditions on the alkaloid content in plants, the production of vincamine through plant cell culture technology has also become one of the research directions, but large-scale commercialization has not yet been achieved.
Pharmacological activity research
The pharmacological activity research of Changchun amine has gone through decades, and has expanded from the initial cerebrovascular effects to multiple fields such as metabolic regulation, demonstrating the characteristics of multi-target and multi pathway effects.
1. Cerebrovascular and neuroprotective activity:
This is the most classic and confirmed core activity of vincamine. It is classified as a peripheral vasodilator, but has a significant selective regulatory effect on cerebral microvascular circulation. Its main manifestations are: increasing cerebral blood flow, especially improving blood supply to ischemic areas; Reduce cerebral vascular resistance; Improve the utilization of oxygen and glucose by brain tissue. The effect of improving cerebral microcirculation is not simply systemic vasodilation, but involves direct action on smooth muscle of cerebral arteries and regulation of neuronal vascular coupling. Based on these effects, Changchun amine has been used for a long time to treat symptoms related to cerebral vascular dysfunction, such as memory loss, dizziness, tinnitus, retinal circulation disorders, etc.
2. Metabolic regulation and anti diabetes activity:
This is the most promising emerging pharmacological activity of vincamine in recent years. Research has found that vincamine is an effective agonist of free fatty acid receptor 1 (FFAR1/GPR40). GPR40 is mainly expressed in pancreatic beta cells and intestinal endocrine cells. Changchun amine can significantly enhance glucose stimulated insulin secretion (GSIS) by activating this receptor, and this process is glucose dependent, promoting insulin release only when blood sugar is elevated, thereby reducing the risk of inducing hypoglycemia. In various animal models of type 2 diabetes, vinblastine administration has shown the effects of improving glucose tolerance, reducing fasting and postprandial blood glucose, and protecting β cells from glycolipid toxicity. This provides a solid experimental basis for its shift from traditional cerebrovascular drugs to the treatment of metabolic diseases.
3. Other potential activities:
The study also suggests that vincamine may have antioxidant, anti-inflammatory, and slightly improved cognitive function effects, which may be related to its improvement of brain energy metabolism and microenvironment. However, the specific mechanism and clinical significance still need further exploration.
Mechanism of action and molecular targets
The multiple pharmacological activities of vincamine stem from its interactions with multiple molecular targets, forming a complex network.
1. Target network related to cerebral vasodilation:
The mechanism of cerebral vasodilation of vincamine is complex, involving multiple targets such as ion channels, enzymes, and receptors, forming a synergistic network:
* Ion channel regulation Research has shown that vincamine can inhibit voltage-gated potassium channels (such as homologs of KCNH2/hERG channels) and voltage-gated calcium channels (such as pathways related to SLC8A1/NCX1 sodium calcium exchangers), affecting the membrane potential and calcium ion homeostasis of vascular smooth muscle cells, leading to smooth muscle relaxation.
* Enzyme activity regulation Changchun amine can upregulate the expression or activity of endothelial nitric oxide synthase (NOS3), promote the release of nitric oxide (NO) from endothelial cells, and NO is a powerful endogenous vasodilator.
* Receptor interaction There is evidence to suggest that vincamine may indirectly regulate vascular tone by affecting the signal transduction of adrenergic β 1 receptor (ADRB1). In addition, it may also have a regulatory effect on the key enzyme of the renin-angiotensin system (RAS), angiotensin-converting enzyme (ACE), thereby affecting the level of local angiotensin II.
2. GPR40 activation and insulin secretion mechanism:
This is the core mechanism of its anti diabetes effect. Changchun amine, as an agonist of GPR40, binds to the receptor and activates Gq protein, which in turn activates phospholipase C (PLC), producing inositol triphosphate (IP3) and diacylglycerol (DAG). IP3 promotes the release of calcium ions from the endoplasmic reticulum, leading to an increase in intracellular calcium concentration; DAG activates protein kinase C (PKC). The synergistic effect of the two ultimately promotes the exocytosis of insulin secreting vesicles and releases insulin. This pathway perfectly integrates glucose metabolism signals (ATP increase) and fatty acid receptor signals, efficiently and controllably promoting insulin secretion.
3. Multi target synergistic effect:
It is worth noting that there may be an inherent connection between the improving effects of vincamine on cerebral blood vessels and metabolic systems. For example, improving cerebral blood flow and energy supply may indirectly benefit the central blood glucose regulation center (such as the hypothalamus); The improvement of systemic glucose metabolism may also alleviate the microvascular diseases related to diabetes, including cerebrovascular diseases. Its multi-target nature makes it possible to have a positive impact on multiple pathological stages of the disease simultaneously.
Evaluation of drug properties and pharmacokinetics
Based on its physicochemical properties and existing research data, vincamine exhibits potential as a central nervous system drug and oral metabolic regulator, but there are also some challenges.
Pharmacokinetic characteristics After oral administration of vincamine, its absorption is rapid but incomplete, and its absolute bioavailability is limited due to first pass effects. It is widely distributed in the body, and due to its high lipophilicity and moderate molecular weight, it can efficiently penetrate the blood-brain barrier and achieve effective therapeutic concentrations in the central nervous system, which is the key to its brain therapeutic effect. Changchun amine is mainly metabolized in the liver through the cytochrome P450 enzyme system (especially CYP2D6 and CYP3A4), undergoing demethylation, hydroxylation, and other reactions to produce various metabolites, some of which may be active. The prototype drug and its metabolites are mainly excreted through the kidneys. The half-life is relatively short, about 1-2 hours, which may require multiple daily doses or the development of sustained-release formulations to maintain stable blood drug concentrations.
Pharmaceutical advantages：
1. Clear brain targeting High blood-brain barrier permeability is its fundamental advantage in treating cerebrovascular diseases.
2. Good security foundation Long term clinical use history (mainly in Europe) has accumulated a considerable amount of safety data, and it is known that adverse reactions are usually mild (such as gastrointestinal discomfort, flushing, headache). The negative hERG inhibition and Ames test provide preliminary guarantees for its cardiovascular and genetic safety.
3. Novel mechanism of action (GPR40)In the field of diabetes, its GPR40 activation has the unique advantage of glucose dependence, which can reduce the risk of hypoglycemia.
Drug Challenge：
1. Poor water solubility: Affects its oral absorption and formulation development.
2. The first pass effect is significant Causing low oral bioavailability.
3. Complex mechanism of action The multi-target characteristic is both an advantage and a challenge, which may lead to unpredictable drug interactions or off target effects, requiring more precise mechanism research.
4. Patent and Development Positioning As a known compound, the development of its new indications (such as diabetes) requires new clinical research evidence and intellectual property layout.
Clinical application prospects and prospects
The clinical application prospects of Changchun amine are expanding from traditional single field to diversified and precise direction.
1. In the field of cerebrovascular diseases:
In this traditional field, the application of vincamine and its derivatives (such as vinpocetine) is tending towards refinement. Future research may focus more on specific populations, such as patients with early cognitive decline accompanied by cerebral microcirculation disorders, patients in recovery after ischemic stroke, or patients with diabetes combined with cerebrovascular disease. As part of a combination therapy regimen, it may have a synergistic effect when used in combination with antiplatelet drugs, statins, or neuroprotective agents. Developing new drug delivery systems, such as nano formulations and transdermal patches, to enhance their brain targeting and long-lasting effects is also an important direction.
2. Treatment of type 2 diabetes and its complications:
This is the most promising new direction for Changchun amine. As a GPR40 agonist, vincamine provides a new mechanism of action for the treatment of T2DM. Its glucose dependent insulin secretion promoting effect is theoretically safer than traditional insulin secretagogues such as sulfonylureas. Future clinical research needs to clarify its effective dose in diabetes patients, long-term efficacy, protective effect on beta cell function, and potential benefits for diabetes complications (such as neuropathy and nephropathy). It may be used as an auxiliary drug for first-line treatment, or for diabetes patients with specific pathophysiological types (such as beta cell dysfunction).
3. Multi disease co treatment and personalized medicine:
Considering that T2DM often coexists with cerebrovascular disease and cognitive impairment, the unique dual mechanism of action of vincamine (improving cerebral circulation and regulating glucose metabolism) makes it an ideal candidate drug for treating this comorbidity. Future research can explore its therapeutic value in diabetes related cognitive dysfunction (such as diabetes encephalopathy). In addition, based on pharmacogenomics, studying the impact of CYP2D6 and other metabolic enzyme gene polymorphisms on the efficacy and safety of vincamine can help achieve personalized medication.
4. Structural optimization and new drug development:
Structural modification using vincamine as the parent nucleus aims to improve its water solubility, metabolic stability, selective activation activity towards GPR40, or reduce its impact on other unexpected targets, which is a research hotspot for medicinal chemists. Through semi synthetic or fully synthetic methods, it is possible to obtain a new generation of derivatives with stronger activity and better drug properties.
Conclusion
Changchun amine, a natural indole alkaloid derived from Changchun flowers, has evolved from a classic vasodilator to a multi-target regulatory molecule that connects the cerebrovascular system and energy metabolism system after more than half a century of research. Its profound traditional application background provides endorsement for safety, while the newly discovered GPR40 agonist activity injects new vitality into it. From improving brain microcirculation to protecting pancreatic beta cells and regulating glucose homeostasis, the spectrum of action of vincamine reveals the multidimensional possibilities of natural products intervening in complex disease networks. Although challenges such as water solubility and first pass effects still exist in drug development, these challenges are expected to be gradually overcome through modern medicinal chemistry, formulation studies, and precision medicine methods. Looking forward to the future, vinblastine is not only expected to continue to play a role in the treatment of cerebrovascular diseases, but also may occupy a place in the new treatment strategy of type 2 diabetes and its comorbidity with cognitive impairment. The continuous in-depth mechanism research, clinical validation, and product development of this ancient natural molecule will be a rediscovery and redefinition of its modern value, fully reflecting the enormous potential of continuously exploring modern treatment options from traditional medicinal plants.
